BioLineRx

(NASDAQ) BLRX

Current Price$3.37

Market Cap$14.72M

Since IPO (2011)-100%

5 Year-97%

1 Year-36%

1 Month+8%

BioLineRx Financials at a Glance

Market Cap

$14.72M

Revenue (TTM)

$1.40M

Net Income (TTM)

-$8.89M

EPS (TTM)

-$2.14

P/E Ratio

-1.57

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$3.37

Volume

Open

$3.47

Price

$3.37

Volume

Open

$3.47

Previous Close

$3.37

Daily Range

$3.37 - $3.53

52-Week Range

$2.15 - $5.06

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

0.81 (Low)

Price

$3.37

Volume

Open

$3.47

Previous Close

$3.37

Daily Range

$3.37 - $3.53

52-Week Range

$2.15 - $5.06

Estimated Earnings Date

Aug 13, 2026

BLRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioLineRx

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Philip Adam Serlin, MBA, CPA

Website

www.biolinerx.com

Headquarters

Hevel Modi'in, 7177871, IL

BLRX Financials

Key Financial Metrics (TTM)

Gross Margin

75%

Operating Margin

-8%

Net Income Margin

-6%

Return on Equity

-48%

Return on Capital

-44%

Return on Assets

-23%

Earnings Yield

-63.69%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.72M

Shares Outstanding

4.37M

Volume

Avg. Volume

49.47K

Financials (TTM)

Gross Profit

$430.39K

Operating Income

-$10.37M

EBITDA

-$224.77K

Operating Cash Flow

-$8.14M

Capital Expenditure

-$25.20K

Free Cash Flow

-$8.16M

Cash & ST Invst.

$20.88M

Total Debt

$10.15M

BioLineRx Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$477.00K

+87.1%

Gross Profit

$382.00K

+72.9%

Gross Margin

80.08%

N/A

Market Cap

$14.72M

N/A

Market Cap/Employee

$525.76K

N/A

Employees

N/A

Net Income

-$2.58M

-150.3%

EBITDA

-$2.25M

-139.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$17.35M

-34.2%

Total Debt

$9.07M

-34.0%

Accounts Receivable

$1.89M

-1.6%

Inventory

$2.16M

-34.9%

Long Term Debt

$4.34M

-49.7%

Short Term Debt

$4.73M

-7.7%

Return on Assets

-22.97%

N/A

Return on Invested Capital

-43.58%

N/A

Free Cash Flow

-$2.29M

+11.8%

Operating Cash Flow

-$2.28M

+12.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MBRXMoleculin Biotech, Inc.

MBRXMoleculin Biotech, Inc.$2.64-2.22%

APLMApollomics, Inc.

APLMApollomics, Inc.$14.31+4.42%

LNAILunai Bioworks Inc.

LNAILunai Bioworks Inc.$2.41-3.60%

AIMDAinos, Inc.

AIMDAinos, Inc.$1.91-0.52%

ICUSeaStar Medical Holding Corporation

ICUSeaStar Medical Holding Corporation$2.98+9.16%

GOVXGeoVax Labs, Inc.

GOVXGeoVax Labs, Inc.$1.22+3.39%

ADTXAditxt, Inc.

ADTXAditxt, Inc.$0.01-2.31%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

Questions About BLRX

What is the current price of BioLineRx?

BioLineRx is trading at $3.37 per share.

What is the 52-week range for BioLineRx?

Over the past 52 weeks, BioLineRx has traded between $2.15 and $5.06.

How much debt does BioLineRx have?

As of the most recent reporting period, BioLineRx reported total debt of $9.07M.

How much cash does BioLineRx have on hand?

BioLineRx reported $2.50M in cash and cash equivalents in its most recent financial results.

What is BioLineRx’s dividend yield?

BioLineRx does not currently have a dividend yield.

BioLineRx

BioLineRx Financials at a Glance

BLRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About BioLineRx

BLRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

BioLineRx Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BLRX

What is the current price of BioLineRx?

What is the 52-week range for BioLineRx?

How much debt does BioLineRx have?

How much cash does BioLineRx have on hand?

What is BioLineRx’s dividend yield?

Premium Investing Services